- Home
- »
- Biotechnology
- »
-
3D Cell Culture Market Size, Share & Trends Report, 2030GVR Report cover
![3D Cell Culture Market Size, Share & Trends Report]()
3D Cell Culture Market Size, Share & Trends Analysis Report By Technology (Scaffold Based, Scaffold Free, Bioreactors, Microfluidics, Bioprinting), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030
- Report ID: GVR-1-68038-091-0
- Number of Report Pages: 125
- Format: PDF, Horizon Databook
- Historical Range: 2018 - 2023
- Forecast Period: 2023 - 2030
- Industry: Healthcare
3D Cell Culture Market Size & Trends
The global 3D cell culture market size was estimated at USD 1.57 billion in 2023 and is expected to expand at a compound annual growth rate (CAGR) of 11.22% from 2024 to 2030. The growth of the market can be attributed to the rising efforts to develop potential alternatives to animal-based testing and the availability of funding programs for research. Moreover, consistent efforts in R&D activities by biopharmaceutical companies for drug development & discovery, and emphasis on the adoption of 3D cell cultures in cancer research are other factors anticipated to fuel market growth over the projected period. Animal models are largely used in cellular-based studies for studying the outlook of various diseases. However, they carry several demerits such as a lack of response accuracy, differences in response from different species, etc. Thus, to manage these issues, various government organizations are involved in promoting alternative ways for drug development.
The COVID-19 pandemic had a significant impact on the market. The COVID-19 pandemic has presented researchers with the opportunity to investigate the novel contagious virus for the creation of therapeutic and diagnostic tools. Numerous prominent pharmaceutical and biotechnology companies have been engaging in extensive R&D efforts to produce innovative vaccines, therapies, and testing kits. As a result, there has been a substantial increase in the need for cell culture tools in research applications. Furthermore, the pandemic has increased the demand for new cell-based models, organoids, and high-throughput screening platforms for research & drug discovery efforts. The urgency to combat the pandemic increased the demand for bioreactors and culture systems for applications in vaccine production and drug testing.
The rising burden of chronic diseases, and medical ailments such as multiple organ failure has created a robust demand for organ transplants. Whereas the dearth of donors has propelled the demand for alternative solutions, like regenerative medicine and tissue engineering. The 3D cell cultures system has an important role in nurturing organoids and functional tissue constructs for transplantation and drug analysis responses. Moreover, companies are launching products that would significantly boost the applications for tissue culture and tissue engineering. For instance, in June 2023, 3D BioFibR announced the launch of two novel 3D bioprinting collagen fiber products (CollaFibR 3D scaffold and μCollaFibR) for improved 3D cell culture.
Moreover, pharmaceutical companies, academic institutions, and research institutes are partnering to advance 3D cell culture technology. Such efforts accelerate technology advancement, knowledge sharing, and standardization of protocols, resulting in the larger adoption of 3D cell culture techniques. In addition, the supportive government legislation, and funding support from public and private organizations have accelerated the R&D activities in the market. For instance, in March 2023, ZEISS Ventures invested in InSphero to promote 3D cell culture research. Similarly, in November 2023, HeartBeat.bio got an investment of USD 4.94 million (€4.5 million) for the development of a specific type of platform which is 3D human tissue-based drug discovery for heart diseases.
Furthermore, robust demand for in-vitro testing models from a range of end users, and several organic and inorganic initiatives undertaken by market players is anticipated to facilitate market expansion in coming years. For instance, in December 2023, Charles River Laboratories announced their agreement with CELLphenomics, which is anticipated to expand their 3D in vitro services that would be used for drug screening purposes for cancer therapy. Similarly, in October 2020 Merck collaborated with D1 Med to accelerate manufacturing of D1Med’s 3-dimensional cells culture technology applications adopted in the drug development process.
Market Concentration & Characteristics
The market growth stage is medium, and the pace of the market growth is accelerating. The market for 3D cell culture is characterized by a high degree of innovation owing to rapid technological advancements. Moreover, the emergence of microfluidics-based 3D cell model (which is a type of cell culture) has further fueled the growth of the market. Several pharmaceutical companies & researchers are using this platform for better accuracy and is a reliable model for toxicity testing and drug screening. In May 2023, CellFE announced the launch of a new microfluidics cellular engineering platform, Infinity Mtx in the annual meeting of the American Society of Cell and Gene Therapy (ASGCT) 2023.
The market is also characterized by a high level of partnerships and collaboration activity undertaken by the leading players. This is attributed to the rising focus on increasing the company’s products & services portfolio, the need to consolidate in a rapidly growing market, and the increasing strategic importance of 3D cell model. Several companies are undertaking this strategy to strengthen their portfolio. For instance, in May 2023, Kiyatec and AstraZeneca announced their collaboration for multifaceted research which would be using Kiyatec’s 3D spheroid screening platform, KIYA-Predict to develop and commercialize a new therapeutics for cancer.
Regulatory authorities are focusing on establishing stringent guidelines for biosafety, contamination control, cell line authentication, and other factors. Hence, compliance with regulatory standards represents significant challenges that may limit market growth. 3D cell models products intended for clinical or commercial use must comply with rigorous quality and safety standards set by regulatory authorities. These standards may include Good Manufacturing Practices (GMPs) and quality control measures to ensure the consistency, purity, and safety of the final products. Meeting these regulatory requirements necessitates meticulous documentation and validation of procedures, which can increase the complexity and cost of cell culture operations. These factors may lead to limited adoption of 3D cell culture techniques and restrict market growth.
Several companies are expanding their 3D cell culture products. Thus, product expansion in this industry is significant. Companies are including product launches that specifically use 3D cell models for research purposes that are anticipated to drive market growth. For instance, in December 2023, Inventia Life Science, introduced a new product, Inventia Third Dimension Grant. This is projected to assist researchers with their studies regarding drug development or fundamental biology to model and test assumptions using 3D cell culture technology.
Technology Insights
The scaffold-based segment held the largest market share of 48.94% in 2023. The segment is further divided into hydrogels, polymeric scaffolds, micropatterned surfaced microplates, and nanofiber-based scaffolds. Factors such as increasing application of scaffold-based cultures in tissue engineering and regenerative medicine applications, advancements in scaffold materials and fabrication techniques, and increasing research funding and collaboration are anticipated to drive segment growth. The use of hydrogels as a scaffold in 3D cell culture model studies allows the incorporation of biochemical and mechanical signs as a mirror of the native extracellular matrix.
In addition, technological advancements, ongoing research activities, and recent product launches are projected to fuel segment growth. In June 2022, Dolomite Bio launched novel hydrogel-focused reagent kits for high-throughput encapsulation of cells in hydrogel scaffold. Furthermore, ongoing research efforts to develop scaffold-based technologies are another factor supporting 3D cell culture market expansion. For instance, in May 2023, researchers from NUS successfully used common plant protein to 3D print an edible cell culture scaffold.
The scaffold free segment is expected to register the fastest CAGR over the forecast period. Factors such as enhanced cellular interactions, higher throughput, and scalability, rising demand for personalized medicine, and advancements in 3D culture model platforms and technologies are responsible for the fastest growth of the segment. In addition, robust demand for scaffold-free systems across end users such as the biopharmaceutical industry and research institutes is another factor catering to segment demand
Application Insights
Based on application, the market is segmented into cancer research, stem cell research & tissue engineering, drug development & toxicity testing, and others. The stem cell research & tissue engineering segment dominated the market with a share in 2023. The increasing demand for biopharmaceuticals owing to effective treatments like cell and gene therapy and the upswing in innovation that resulted in increased approvals are the key factors contributing to segment growth.
It is expected that the U.S. FDA will be approving around 10 to 20 products of cell and gene therapy each year by 2025 based on the current clinical success rates and the product pipeline. Also, technological advancements, supportive government legislation, and increased funding for stem cell studies have propelled the adoption of 3D culture models. For instance, in March 2023 National Institute of Health granted funding of USD 2.5 million to the research team of Purdue University for stem cell research. The funding will support the investigation of novel therapeutic approaches with stem cells as it has tremendous potential in various life-threatening disorders.
The cancer research segment is expected to register the fastest CAGR over the forecast period. The rising prevalence of cancer and the benefits offered by 3D culture models in cancer research are expected to drive segment expansion. Moreover, the advantages of 3D media in altering cell proliferation and morphology, capturing phenotypic heterogeneity, and flexibility offered by these media further support segment expansion.
End-use Insights
Based on end-use, the market is segmented into biotechnology & pharmaceutical companies, academic & research institutes, hospitals, and others. The biopharmaceutical & pharmaceutical companies segment dominated the market with a share in 2023. The continuous growth and commercial success of biopharmaceuticals coupled with leveraging the portfolio of the major pharmaceutical companies have contributed to the segment growth. 3D model offers benefits such the optimal oxygen & nutrient gradient formation and realistic cellular interactions in comparison to two-dimensional cellular media to study drugs. These factors facilitate the adoption of this method for drug discovery & development, thereby fueling the demand.
The academic & research institutes segment is expected to register the fastest CAGR during the forecast period. Factors such as advancements in biomedical research, increasing research activities, rising industry-academia collaboration, and significant efforts from research institutions in drug modelling and drug screening are anticipated to accelerate segment growth.
Regional Insights
North America dominated the market and accounted for a 38.97% share in 2023. The market is collectively driven by the presence of advanced healthcare infrastructure, developed economies, the presence of key players, and various strategic initiatives undertaken by them. In addition, a supportive regulatory framework, government support for the development of three-dimensional culture models, and a high number of research organizations and universities investigating different stem-cells based approaches are projected to support the regional market. For instance, in April 2023, the American Cancer Society (ACS) announced the funding of more than USD 45 million for 90 novel Extramural Discovery Science (EDS) research at 67 institutes across the U.S.
Asia Pacific is anticipated to witness the fastest growth in the market from 2024 to 2030. The high burden of chronic diseases, the flourishing biotechnology sector in the region, low operating costs, and rising investments by companies in the region are fueling the regional market. Moreover, rising demand for cellular therapies, increasing biobanks, and strong research potential are further contributing to the regional market.
Key 3D Cell Culture Company Insights
Prominent players operating in the market are undertaking strategic activities such as new product launches, partnerships for product development, and investment activities to fuel market growth in the coming years.
Key 3D Cell Culture Companies:
The following are the leading companies in the 3D cell culture market. These companies collectively hold the largest market share and dictate industry trends. Financials, strategy maps & products of these 3D cell culture companies are analyzed to map the supply network.
- Thermo Fisher Scientific, Inc.
- Merck KGaA
- PromoCell GmbH
- Lonza
- Corning Incorporated
- Avantor, Inc.
- Tecan Trading AG
- REPROCELL Inc.
- CN Bio Innovations Ltd
- Lena Biosciences
Recent Developments
-
In September 2023, Curi bio announced the launch of two platforms, that is, Nautilus and Stringray. These platforms are anticipated to assist researchers with their 2D or 3D cell culture interrogation on electrophysiology.
-
In July 2023, REPROCELL Inc. entered into a partnership with Vernal Biosciences to deliver mRNA services at scale for clinical and research applications in Japan. This strategy is aligned with REPROCELL’s aim to introduce cutting-edge preclinical & clinical research solutions to the market.
-
In July 2023, 3D BioFibR, a Canada-based company, received an investment of nearly USD 3.52 million to expand the facility and launch collagen fiber products used for 3D bioprinting.
-
In June 2023, Lonza entered into a strategic business collaboration with Vertex Pharmaceuticals Incorporated, with an aim to support the production of Vertex’s range of fully differentiated insulin-producing, investigational stem cell-derived islet cell therapies for individuals with Type 1 diabetes and to speed up the clinical trials.
-
In February 2023, Corning Life Sciences announced its plans to unveil its advanced 3D culture tools and a new Elplasia plate featuring an open-well format for easing spheroid and organoid manipulations.
-
In February 2023, CN Bio announced the commercial product launch of the PhysioMimix - a single-organ higher throughput system. The system is developed to allow the earlier adoption of predictive models of liver Organ-on-a-Chip for humans in drug discovery workflows. By deploying 3D cell culture systems including PhysioMimix, researchers can more efficiently simulate the behavior of organs & tissues, leading to more relevant and reliable preclinical research results.
-
In January 2023, CD BioSciences launched scaffold-based technology to help scientists achieve organotypic co-culture and simulate layered tissue structures.
3D Cell Culture Market Report Scope
Report Attribute
Details
Market size value in 2024
USD 1.70 billion
Revenue forecast in 2030
USD 3.21 billion
Growth Rate
CAGR of 11.22% from 2024 to 2030
Actual data
2018 - 2023
Forecast period
2024 - 2030
Quantitative units
Revenue in USD million and CAGR from 2024 to 2030
Report coverage
Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered
Technology, application, end-use, region
Regional scope
North America; Europe; Asia Pacific; Latin America; MEA
Country scope
U.S.; Canada; Germany; UK; France; Italy; Spain; Denmark; Sweden; Norway; China; Japan; India; South Korea; Australia; Thailand; Brazil; Mexico, Argentina; South Africa; Saudi Arabia, UAE; Kuwait
Key companies profiled
Thermo Fisher Scientific, Inc.; Merck KGaA, PromoCell GmbH; Lonza; Corning Incorporated; Avantor, Inc.; Tecan Trading AG; REPROCELL Inc.; CN Bio Innovations Ltd; Lena Biosciences.
Customization scope
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options
Avail customized purchase options to meet your exact research needs. Explore purchase options
Global 3D Cell Culture Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global 3D cell culture market report based on technology, application, end-use, and region.
-
Technology Outlook (Revenue, USD Billion, 2018 - 2030)
-
Scaffold Based
-
Hydrogels
-
Polymeric Scaffolds
-
Micropatterned Surface Microplates
-
Nanofiber Base Scaffolds
-
-
Scaffold Free
-
Hanging Drop Microplates
-
Spheroid Microplates with ULA Coating
-
Magnetic Levitation
-
-
Bioreactors
-
Microfluidics
-
Bioprinting
-
-
Application Outlook (Revenue, USD Billion, 2018 - 2030)
-
Cancer Research
-
Stem Cell Research & Tissue Engineering
-
Drug Development & Toxicity Testing
-
Others
-
-
End Use Outlook (Revenue, USD Billion, 2018 - 2030)
-
Biotechnology and Pharmaceutical Companies
-
Academic & Research Institutes
-
Hospitals
-
Others
-
-
Regional Outlook (Revenue, USD Billion, 2018 - 2030)
-
North America
-
U.S.
-
Canada
-
-
Europe
-
Germany
-
UK
-
France
-
Italy
-
Spain
-
Denmark
-
Sweden
-
Norway
-
-
Asia Pacific
-
China
-
Japan
-
India
-
South Korea
-
Australia
-
Thailand
-
-
Latin America
-
Brazil
-
Mexico
-
Argentina
-
-
Middle East & Africa
-
South Africa
-
Saudi Arabia
-
UAE
-
Kuwait
-
-
Frequently Asked Questions About This Report
b. Key factors that are driving the 3D cell culture market growth include rising demand for organ transplantation & tissue engineering, technological advancements in scaffold-free technology, and a rise in investments and R&D funding for cell-based research.
b. The global 3D cell culture market size was estimated at USD 1.57 billion in 2023 and is expected to reach USD 1.70 billion by 2024.
b. The global 3D cell culture market is expected to grow at a compound annual growth rate of 11.22% from 2024 to 2030 to reach USD 3.21 billion by 2030.
b. Scaffold-based technology segment dominated the 3D cell culture market with a share of 48.94% in 2023. This is attributable to the availability of a significant number of products for scaffold-based 3D cell culture.
b. Some key players operating in the 3D cell culture market include Thermo Fisher Scientific, Inc.; Merck KGaA, PromoCell GmbH; Lonza; Corning Incorporated; Avantor, Inc.; Tecan Trading AG; REPROCELL Inc.; CN Bio Innovations Ltd; Lena Biosciences.
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Technology Segment
1.1.2. Application Segment
1.1.3. End Use Segment
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information or Data Analysis:
1.6.1. Data Analysis Models
1.7. Market Formulation & Validation
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing demand for organ transplantation & tissue engineering
3.2.1.2. Technological advancements in scaffold free technology
3.2.1.3. Rise in investments and R&D funding for cell-based research
3.2.1.4. Increasing focus on developing alternative to animal testing
3.2.2. Market Restraint Analysis
3.2.2.1. High cost associated with implementation
3.2.2.2. Lack of compatibility and consistency
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Technology Business Analysis
4.1. 3D Cell Culture Market: Technology Movement Analysis
4.2. Scaffold Based
4.2.1. Scaffold based market estimates and forecasts, 2018 - 2030 (USD Million)
4.2.2. Hydrogels
4.2.2.1. Hydrogels market estimates and forecasts, 2018 - 2030 (USD Million)
4.2.3. Polymeric Scaffolds
4.2.3.1. Polymeric scaffolds market estimates and forecasts, 2018 - 2030 (USD Million)
4.2.4. Micropatterned Surface Microplates
4.2.4.1. Micropatterned surface microplates market estimates and forecasts, 2018 - 2030 (USD Million)
4.2.5. Nanofiber Based Scaffolds
4.2.5.1. Nanofiber based scaffolds market estimates and forecasts, 2018 - 2030 (USD Million)
4.3. Scaffold Free
4.3.1. Scaffold free market estimates and forecasts, 2018 - 2030 (USD Million)
4.3.2. Hanging Drop Microplates
4.3.2.1. Hanging drop microplates market estimates and forecasts, 2018 - 2030 (USD Million)
4.3.3. Spheroid Microplates with ULA coating
4.3.3.1. Spheroid microplates with ULA coating market estimates and forecasts, 2018 - 2030 (USD Million)
4.3.4. Magnetic Levitation
4.3.4.1. Magnetic levitation market estimates and forecasts, 2018 - 2030 (USD Million)
4.4. Bioreactors
4.4.1. Bioreactors market estimates and forecasts, 2018 - 2030 (USD Million)
4.5. Microfluidics
4.5.1. Microfluidics market estimates and forecasts, 2018 - 2030 (USD Million)
4.6. Bioprinting
4.6.1. Bioprinting market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 5. Application Business Analysis
5.1. 3D Cell Culture Market: Application Movement Analysis
5.2. Cancer Research
5.2.1. Cancer research market estimates and forecasts, 2018 - 2030 (USD Million)
5.3. Stem Cell Research & Tissue Engineering
5.3.1. Stem cell research & tissue engineering market estimates and forecasts, 2018 - 2030 (USD Million)
5.4. Drug Development & Toxicity Testing
5.4.1. Drug development & toxicity testing market estimates and forecasts, 2018 - 2030 (USD Million)
5.5. Others
5.5.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 6. End-Use Business Analysis
6.1. 3D Cell Culture Market: End-Use Movement Analysis
6.2. Biotechnology & Pharmaceutical Companies
6.2.1. Biotechnology & pharmaceutical companies market estimates and forecasts, 2018 - 2030 (USD Million)
6.3. Academic & Research Institutes
6.3.1. Academic & research institutes market estimates and forecasts, 2018 - 2030 (USD Million)
6.4. Hospitals
6.4.1. Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
6.5. Others
6.5.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 7. Regional Business Analysis
7.1. 3D Cell Culture Share By Region, 2023 & 2030
7.2. North America
7.2.1. North America 3D Cell Culture, 2018 - 2030 (USD Million)
7.2.2. U.S.
7.2.2.1. Key Country Dynamics
7.2.2.2. Competitive Scenario
7.2.2.3. Target Disease Prevalence
7.2.2.4. U.S. 3D Cell Culture, 2018 - 2030 (USD Million)
7.2.3. Canada
7.2.3.1. Key Country Dynamics
7.2.3.2. Competitive Scenario
7.2.3.3. Target Disease Prevalence
7.2.3.4. Canada 3D Cell Culture, 2018 - 2030 (USD Million)
7.3. Europe
7.3.1. Europe 3D Cell Culture, 2018 - 2030 (USD Million)
7.3.2. UK
7.3.2.1. Key Country Dynamics
7.3.2.2. Competitive Scenario
7.3.2.3. Target Disease Prevalence
7.3.2.4. UK 3D Cell Culture, 2018 - 2030 (USD Million)
7.3.3. Germany
7.3.3.1. Key Country Dynamics
7.3.3.2. Competitive Scenario
7.3.3.3. Target Disease Prevalence
7.3.3.4. Germany 3D Cell Culture, 2018 - 2030 (USD Million)
7.3.4. France
7.3.4.1. Key Country Dynamics
7.3.4.2. Competitive Scenario
7.3.4.3. Target Disease Prevalence
7.3.4.4. France 3D Cell Culture, 2018 - 2030 (USD Million)
7.3.5. Italy
7.3.5.1. Key Country Dynamics
7.3.5.2. Competitive Scenario
7.3.5.3. Target Disease Prevalence
7.3.5.4. Italy 3D Cell Culture, 2018 - 2030 (USD Million)
7.3.6. Spain
7.3.6.1. Key Country Dynamics
7.3.6.2. Competitive Scenario
7.3.6.3. Target Disease Prevalence
7.3.6.4. Spain 3D Cell Culture, 2018 - 2030 (USD Million)
7.3.7. Denmark
7.3.7.1. Key Country Dynamics
7.3.7.2. Competitive Scenario
7.3.7.3. Target Disease Prevalence
7.3.7.4. Denmark 3D Cell Culture, 2018 - 2030 (USD Million)
7.3.8. Sweden
7.3.8.1. Key Country Dynamics
7.3.8.2. Competitive Scenario
7.3.8.3. Target Disease Prevalence
7.3.8.4. Sweden 3D Cell Culture, 2018 - 2030 (USD Million)
7.3.9. Norway
7.3.9.1. Key Country Dynamics
7.3.9.2. Competitive Scenario
7.3.9.3. Target Disease Prevalence
7.3.9.4. Norway 3D Cell Culture, 2018 - 2030 (USD Million)
7.4. Asia Pacific
7.4.1. Asia Pacific 3D Cell Culture, 2018 - 2030 (USD Million)
7.4.2. Japan
7.4.2.1. Key Country Dynamics
7.4.2.2. Competitive Scenario
7.4.2.3. Target Disease Prevalence
7.4.2.4. Japan 3D Cell Culture, 2018 - 2030 (USD Million)
7.4.3. China
7.4.3.1. Key Country Dynamics
7.4.3.2. Competitive Scenario
7.4.3.3. Target Disease Prevalence
7.4.3.4. China 3D Cell Culture, 2018 - 2030 (USD Million)
7.4.4. India
7.4.4.1. Key Country Dynamics
7.4.4.2. Competitive Scenario
7.4.4.3. Target Disease Prevalence
7.4.4.4. India 3D Cell Culture, 2018 - 2030 (USD Million)
7.4.5. Australia
7.4.5.1. Key Country Dynamics
7.4.5.2. Competitive Scenario
7.4.5.3. Target Disease Prevalence
7.4.5.4. Australia 3D Cell Culture, 2018 - 2030 (USD Million)
7.4.6. Thailand
7.4.6.1. Key Country Dynamics
7.4.6.2. Competitive Scenario
7.4.6.3. Target Disease Prevalence
7.4.6.4. Thailand 3D Cell Culture, 2018 - 2030 (USD Million)
7.4.7. South Korea
7.4.7.1. Key Country Dynamics
7.4.7.2. Competitive Scenario
7.4.7.3. Target Disease Prevalence
7.4.7.4. South Korea 3D Cell Culture, 2018 - 2030 (USD Million)
7.5. Latin America
7.5.1. Latin America 3D Cell Culture, 2018 - 2030 (USD Million)
7.5.2. Brazil
7.5.2.1. Key Country Dynamics
7.5.2.2. Competitive Scenario
7.5.2.3. Target Disease Prevalence
7.5.2.4. Brazil 3D Cell Culture, 2018 - 2030 (USD Million)
7.5.3. Mexico
7.5.3.1. Key Country Dynamics
7.5.3.2. Competitive Scenario
7.5.3.3. Target Disease Prevalence
7.5.3.4. Mexico 3D Cell Culture, 2018 - 2030 (USD Million)
7.5.4. Argentina
7.5.4.1. Key Country Dynamics
7.5.4.2. Competitive Scenario
7.5.4.3. Target Disease Prevalence
7.5.4.4. Argentina 3D Cell Culture, 2018 - 2030 (USD Million)
7.6. MEA
7.6.1. MEA 3D Cell Culture, 2018 - 2030 (USD Million)
7.6.2. South Africa
7.6.2.1. Key Country Dynamics
7.6.2.2. Competitive Scenario
7.6.2.3. Target Disease Prevalence
7.6.2.4. South Africa 3D Cell Culture, 2018 - 2030 (USD Million)
7.6.3. Saudi Arabia
7.6.3.1. Key Country Dynamics
7.6.3.2. Competitive Scenario
7.6.3.3. Target Disease Prevalence
7.6.3.4. Saudi Arabia 3D Cell Culture, 2018 - 2030 (USD Million)
7.6.4. UAE
7.6.4.1. Key Country Dynamics
7.6.4.2. Competitive Scenario
7.6.4.3. Target Disease Prevalence
7.6.4.4. UAE 3D Cell Culture, 2018 - 2030 (USD Million)
7.6.5. Kuwait
7.6.5.1. Key Country Dynamics
7.6.5.2. Competitive Scenario
7.6.5.3. Target Disease Prevalence
7.6.5.4. Kuwait 3D Cell Culture, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Company Categorization
8.2. Strategy Mapping
8.3. Company Market Position Analysis, 2023
8.4. Company Profiles/Listing
8.4.1. Thermo Fisher Scientific, Inc
8.4.1.1. Overview
8.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.1.3. Product Benchmarking
8.4.1.4. Strategic Initiatives
8.4.2. Merck KGaA
8.4.2.1. Overview
8.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.2.3. Product Benchmarking
8.4.2.4. Strategic Initiatives
8.4.3. PromoCell GmbH
8.4.3.1. Overview
8.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.3.3. Product Benchmarking
8.4.3.4. Strategic Initiatives
8.4.4. Lonza
8.4.4.1. Overview
8.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.4.3. Product Benchmarking
8.4.4.4. Strategic Initiatives
8.4.5. Corning Incorporated
8.4.5.1. Overview
8.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.5.3. Product Benchmarking
8.4.5.4. Strategic Initiatives
8.4.6. Avantor, Inc.
8.4.6.1. Overview
8.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.6.3. Product Benchmarking
8.4.6.4. Strategic Initiatives
8.4.7. Tecan Trading AG
8.4.7.1. Overview
8.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.7.3. Product Benchmarking
8.4.7.4. Strategic Initiatives
8.4.8. REPROCELL Inc.
8.4.8.1. Overview
8.4.8.2. Product Benchmarking
8.4.8.3. Strategic Initiatives
8.4.9. CN Bio Innovations Ltd.
8.4.9.1. Overview
8.4.9.2. Product Benchmarking
8.4.9.3. Strategic Initiatives
8.4.10. Lena Biosciences
8.4.10.1. Overview
8.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
8.4.10.3. Product Benchmarking
8.4.10.4. Strategic Initiatives
List of Tables
Table 1 List of abbreviation
Table 2 Global 3D cell culture market, by region, 2018 - 2030 (USD Million)
Table 3 North America 3D cell culture market, by country, 2018 - 2030 (USD Million)
Table 4 North America 3D cell culture market, by technology, 2018 - 2030 (USD Million)
Table 5 North America 3D cell culture market, by application, 2018 - 2030 (USD Million)
Table 6 North America 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
Table 7 U.S. 3D cell culture market, by technology, 2018 - 2030 (USD Million)
Table 8 U.S. 3D cell culture market, by application, 2018 - 2030 (USD Million)
Table 9 U.S. 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
Table 10 Canada 3D cell culture market, by technology, 2018 - 2030 (USD Million)
Table 11 Canada 3D cell culture market, by application, 2018 - 2030 (USD Million)
Table 12 Canada 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
Table 13 Europe 3D cell culture market, by country, 2018 - 2030 (USD Million)
Table 14 Europe 3D cell culture market, by technology, 2018 - 2030 (USD Million)
Table 15 Europe 3D cell culture market, by application, 2018 - 2030 (USD Million)
Table 16 Europe 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
Table 17 Germany 3D cell culture market, by technology, 2018 - 2030 (USD Million)
Table 18 Germany 3D cell culture market, by application, 2018 - 2030 (USD Million)
Table 19 Germany 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
Table 20 UK 3D cell culture market, by technology, 2018 - 2030 (USD Million)
Table 21 UK 3D cell culture market, by application, 2018 - 2030 (USD Million)
Table 22 UK 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
Table 23 France 3D cell culture market, by technology, 2018 - 2030 (USD Million)
Table 24 France 3D cell culture market, by application, 2018 - 2030 (USD Million)
Table 25 France 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
Table 26 Italy 3D cell culture market, by technology, 2018 - 2030 (USD Million)
Table 27 Italy 3D cell culture market, by application, 2018 - 2030 (USD Million)
Table 28 Italy 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
Table 29 Spain 3D cell culture market, by technology, 2018 - 2030 (USD Million)
Table 30 Spain 3D cell culture market, by application, 2018 - 2030 (USD Million)
Table 31 Spain 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
Table 32 Denmark 3D cell culture market, by technology, 2018 - 2030 (USD Million)
Table 33 Denmark 3D cell culture market, by application, 2018 - 2030 (USD Million)
Table 34 Denmark 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
Table 35 Sweden 3D cell culture market, by technology, 2018 - 2030 (USD Million)
Table 36 Sweden 3D cell culture market, by application, 2018 - 2030 (USD Million)
Table 37 Sweden 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
Table 38 Norway 3D cell culture market, by technology, 2018 - 2030 (USD Million)
Table 39 Norway 3D cell culture market, by application, 2018 - 2030 (USD Million)
Table 40 Norway 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
Table 41 Asia Pacific 3D cell culture market, by country, 2018 - 2030 (USD Million)
Table 42 Asia Pacific 3D cell culture market, by technology, 2018 - 2030 (USD Million)
Table 43 Asia Pacific 3D cell culture market, by application, 2018 - 2030 (USD Million)
Table 44 Asia Pacific 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
Table 45 China 3D cell culture market, by technology, 2018 - 2030 (USD Million)
Table 46 China 3D cell culture market, by application, 2018 - 2030 (USD Million)
Table 47 China 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
Table 48 Japan 3D cell culture market, by technology, 2018 - 2030 (USD Million)
Table 49 Japan 3D cell culture market, by application, 2018 - 2030 (USD Million)
Table 50 Japan 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
Table 51 India 3D cell culture market, by technology, 2018 - 2030 (USD Million)
Table 52 India 3D cell culture market, by application, 2018 - 2030 (USD Million)
Table 53 India 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
Table 54 South Korea 3D cell culture market, by technology, 2018 - 2030 (USD Million)
Table 55 South Korea 3D cell culture market, by application, 2018 - 2030 (USD Million)
Table 56 South Korea 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
Table 57 Australia 3D cell culture market, by technology, 2018 - 2030 (USD Million)
Table 58 Australia 3D cell culture market, by application, 2018 - 2030 (USD Million)
Table 59 Australia 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
Table 60 Thailand 3D cell culture market, by technology, 2018 - 2030 (USD Million)
Table 61 Thailand 3D cell culture market, by application, 2018 - 2030 (USD Million)
Table 62 Thailand 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
Table 63 Latin America 3D cell culture market, by country, 2018 - 2030 (USD Million)
Table 64 Latin America 3D cell culture market, by technology, 2018 - 2030 (USD Million)
Table 65 Latin America 3D cell culture market, by application, 2018 - 2030 (USD Million)
Table 66 Latin America 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
Table 67 Brazil 3D cell culture market, by technology, 2018 - 2030 (USD Million)
Table 68 Brazil 3D cell culture market, by application, 2018 - 2030 (USD Million)
Table 69 Brazil 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
Table 70 Mexico 3D cell culture market, by technology, 2018 - 2030 (USD Million)
Table 71 Mexico 3D cell culture market, by application, 2018 - 2030 (USD Million)
Table 72 Mexico 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
Table 73 Argentina 3D cell culture market, by technology, 2018 - 2030 (USD Million)
Table 74 Argentina 3D cell culture market, by application, 2018 - 2030 (USD Million)
Table 75 Argentina 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
Table 76 MEA 3D cell culture market, by country, 2018 - 2030 (USD Million)
Table 77 MEA 3D cell culture market, by technology, 2018 - 2030 (USD Million)
Table 78 MEA 3D cell culture market, by application, 2018 - 2030 (USD Million)
Table 79 MEA 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
Table 80 South Africa 3D cell culture market, by technology, 2018 - 2030 (USD Million)
Table 81 South Africa 3D cell culture market, by application, 2018 - 2030 (USD Million)
Table 82 South Africa 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
Table 83 Saudi Arabia 3D cell culture market, by technology, 2018 - 2030 (USD Million)
Table 84 Saudi Arabia 3D cell culture market, by application, 2018 - 2030 (USD Million)
Table 85 Saudi Arabia 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
Table 86 UAE 3D cell culture market, by technology, 2018 - 2030 (USD Million)
Table 87 UAE 3D cell culture market, by application, 2018 - 2030 (USD Million)
Table 88 UAE 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
Table 89 Kuwait 3D cell culture market, by technology, 2018 - 2030 (USD Million)
Table 90 Kuwait 3D cell culture market, by application, 2018 - 2030 (USD Million)
Table 91 Kuwait 3D cell culture market, by end-use, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 3D cell culture market: market outlook
Fig. 9 Parent market outlook
Fig. 10 3D cell culture market driver impact
Fig. 11 3D cell culture market restraint impact
Fig. 12 3D cell culture market: technology outlook and key takeaways
Fig. 13 3D cell culture market: technology movement analysis
Fig. 14 Scaffold based market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 15 Hydrogels market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 16 Polymeric scaffolds market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 17 Micropatterned surface microplates market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 18 Nanofiber based scaffolds market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 19 Scaffold free market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 Hanging drop microplates market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Spheroid microplates with ULA coating market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 22 Magnetic levitation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Bioreactors market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 Microfluidics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Bioprinting market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 3D cell culture market: application outlook and key takeaways
Fig. 27 3D cell culture market: application movement analysis
Fig. 28 Cancer research market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 Stem cell research & tissue engineering market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 30 Drug development & toxicity testing market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 31 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 3D cell culture market: end-use outlook and key takeaways
Fig. 33 3D cell culture market: end-use movement analysis
Fig. 34 Biotechnology & pharmaceutical companies market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 Academic & research institutes market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Hospitals market estimates and forecasts,2018 - 2030 (USD Million)
Fig. 37 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 38 North America 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 U.S. 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Canada 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Europe 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 UK 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Germany 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 France 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 Italy 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 Spain 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Denmark 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 Sweden 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 Norway 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 Asia Pacific 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 China 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Japan 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 India 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 Thailand 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 South Korea 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 Australia 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 Latin America 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 Brazil 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 59 Mexico 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 60 Argentina 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 Middle East and Africa 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 62 South Africa 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 63 Saudi Arabia 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 64 UAE 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 65 Kuwait 3D cell culture market estimates and forecasts, 2018 - 2030 (USD Million)Market Segmentation
- 3D Cell Culture Technology Outlook (Revenue, USD Million, 2018 - 2030)
- Scaffold Based
- Hydrogels
- Polymeric Scaffolds
- Micropatterned Surface Microplates
- Nanofiber Based Scaffolds
- Scaffold Free
- Hanging Drop Microplates
- Spheroid Microplates with ULA coating
- Magnetic Levitation
- Bioreactors
- Microfluidic
- Bioprinting
- Scaffold Based
- 3D Cell Culture Application Outlook (Revenue, USD Million, 2018 - 2030)
- Cancer Research
- Stem Cell Research & Tissue Engineering
- Drug Development & Toxicity Testing
- Others
- 3D Cell Culture End-Use Outlook (Revenue, USD Million, 2018 - 2030)
- Biotechnology & Pharmaceutical Companies
- Academic & Research Institutes
- Hospitals
- Others
- 3D Cell Culture Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
- North America 3D Cell Culture Market, By Technology, 2018 - 2030 (USD Million)
- Scaffold Based
- Hydrogels
- Polymeric Scaffolds
- Micropatterned Surface Microplates
- Nanofiber Based Scaffolds
- Scaffold Free
- Hanging Drop Microplates
- Spheroid Microplates with ULA coating
- Magnetic Levitation
- Bioreactors
- Microfluidics
- Bioprinting
- Scaffold Based
- North America 3D Cell Culture Market, By Application, 2018 - 2030 (USD Million)
- Cancer Research
- Stem Cell Research & Tissue Engineering
- Drug Development & Toxicity Testing
- Others
- North America 3D Cell Culture Market, By End Use, 2018 - 2030 (USD Million)
- Biotechnology & Pharmaceutical Companies
- Academic & Research Institutes
- Hospitals
- Others
- U.S.
- U.S. 3D Cell Culture Market, By Technology, 2018 - 2030 (USD Million)
- Scaffold Based
- Hydrogels
- Polymeric Scaffolds
- Micropatterned Surface Microplates
- Nanofiber Based Scaffolds
- Scaffold Free
- Hanging Drop Microplates
- Spheroid Microplates with ULA coating
- Magnetic Levitation
- Bioreactors
- Microfluidics
- Bioprinting
- Scaffold Based
- U.S. 3D Cell Culture Market, By Application, 2018 - 2030 (USD Million)
- Cancer Research
- Stem Cell Research & Tissue Engineering
- Drug Development & Toxicity Testing
- Others
- U.S. 3D Cell Culture Market, By End Use, 2018 - 2030 (USD Million)
- Biotechnology & Pharmaceutical Companies
- Academic & Research Institutes
- Hospitals
- Others
- U.S. 3D Cell Culture Market, By Technology, 2018 - 2030 (USD Million)
- Canada
- Canada 3D Cell Culture Market, By Technology, 2018 - 2030 (USD Million)
- Scaffold Based
- Hydrogels
- Polymeric Scaffolds
- Micropatterned Surface Microplates
- Nanofiber Based Scaffolds
- Scaffold Free
- Hanging Drop Microplates
- Spheroid Microplates with ULA coating
- Magnetic Levitation
- Bioreactors
- Microfluidics
- Bioprinting
- Scaffold Based
- Canada 3D Cell Culture Market, By Application, 2018 - 2030 (USD Million)
- Cancer Research
- Stem Cell Research & Tissue Engineering
- Drug Development & Toxicity Testing
- Others
- Canada 3D Cell Culture Market, By End Use, 2018 - 2030 (USD Million)
- Biotechnology & Pharmaceutical Companies
- Academic & Research Institutes
- Hospitals
- Others
- Canada 3D Cell Culture Market, By Technology, 2018 - 2030 (USD Million)
- North America 3D Cell Culture Market, By Technology, 2018 - 2030 (USD Million)
- Europe
- Europe 3D Cell Culture Market, By Technology, 2018 - 2030 (USD Million)
- Scaffold Based
- Hydrogels
- Polymeric Scaffolds
- Micropatterned Surface Microplates
- Nanofiber Based Scaffolds
- Scaffold Free
- Hanging Drop Microplates
- Spheroid Microplates with ULA coating
- Magnetic Levitation
- Bioreactors
- Microfluidics
- Bioprinting
- Scaffold Based
- Europe 3D Cell Culture Market, By Application, 2018 - 2030 (USD Million)
- Cancer Research
- Stem Cell Research & Tissue Engineering
- Drug Development & Toxicity Testing
- Others
- Europe 3D Cell Culture Market, By End Use, 2018 - 2030 (USD Million)
- Biotechnology & Pharmaceutical Companies
- Academic & Research Institutes
- Hospitals
- Others
- UK
- UK 3D Cell Culture Market, By Technology, 2018 - 2030 (USD Million)
- Scaffold Based
- Hydrogels
- Polymeric Scaffolds
- Micropatterned Surface Microplates
- Nanofiber Based Scaffolds
- Scaffold Free
- Hanging Drop Microplates
- Spheroid Microplates with ULA coating
- Magnetic Levitation
- Bioreactors
- Microfluidics
- Bioprinting
- Scaffold Based
- UK 3D Cell Culture Market, By Application, 2018 - 2030 (USD Million)
- Cancer Research
- Stem Cell Research & Tissue Engineering
- Drug Development & Toxicity Testing
- Others
- UK 3D Cell Culture Market, By End Use, 2018 - 2030 (USD Million)
- Biotechnology & Pharmaceutical Companies
- Academic & Research Institutes
- Hospitals
- Others
- UK 3D Cell Culture Market, By Technology, 2018 - 2030 (USD Million)
- Germany
- Germany 3D Cell Culture Market, By Technology, 2018 - 2030 (USD Million)
- Scaffold Based
- Hydrogels
- Polymeric Scaffolds
- Micropatterned Surface Microplates
- Nanofiber Based Scaffolds
- Scaffold Free
- Hanging Drop Microplates
- Spheroid Microplates with ULA coating
- Magnetic Levitation
- Bioreactors
- Microfluidics
- Bioprinting
- Scaffold Based
- Germany 3D Cell Culture Market, By Application, 2018 - 2030 (USD Million)
- Cancer Research
- Stem Cell Research & Tissue Engineering
- Drug Development & Toxicity Testing
- Others
- Germany 3D Cell Culture Market, By End Use, 2018 - 2030 (USD Million)
- Biotechnology & Pharmaceutical Companies
- Academic & Research Institutes
- Hospitals
- Others
- Germany 3D Cell Culture Market, By Technology, 2018 - 2030 (USD Million)
- France
- France 3D Cell Culture Market, By Technology, 2018 - 2030 (USD Million)
- Scaffold Based
- Hydrogels
- Polymeric Scaffolds
- Micropatterned Surface Microplates
- Nanofiber Based Scaffolds
- Scaffold Free
- Hanging Drop Microplates
- Spheroid Microplates with ULA coating
- Magnetic Levitation
- Bioreactors
- Microfluidics
- Bioprinting
- Scaffold Based
- France 3D Cell Culture Market, By Application, 2018 - 2030 (USD Million)
- Cancer Research
- Stem Cell Research & Tissue Engineering
- Drug Development & Toxicity Testing
- Others
- France 3D Cell Culture Market, By End Use, 2018 - 2030 (USD Million)
- Biotechnology & Pharmaceutical Companies
- Academic & Research Institutes
- Hospitals
- Others
- France 3D Cell Culture Market, By Technology, 2018 - 2030 (USD Million)
- Italy
- Italy 3D Cell Culture Market, By Technology, 2018 - 2030 (USD Million)
- Scaffold Based
- Hydrogels
- Polymeric Scaffolds
- Micropatterned Surface Microplates
- Nanofiber Based Scaffolds
- Scaffold Free
- Hanging Drop Microplates
- Spheroid Microplates with ULA coating
- Magnetic Levitation
- Bioreactors
- Microfluidics
- Bioprinting
- Scaffold Based
- Italy 3D Cell Culture Market, By Application, 2018 - 2030 (USD Million)
- Cancer Research
- Stem Cell Research & Tissue Engineering
- Drug Development & Toxicity Testing
- Others
- Italy 3D Cell Culture Market, By End Use, 2018 - 2030 (USD Million)
- Biotechnology & Pharmaceutical Companies
- Academic & Research Institutes
- Hospitals
- Others
- Italy 3D Cell Culture Market, By Technology, 2018 - 2030 (USD Million)
- Spain
- Spain 3D Cell Culture Market, By Technology, 2018 - 2030 (USD Million)
- Scaffold Based
- Hydrogels
- Polymeric Scaffolds
- Micropatterned Surface Microplates
- Nanofiber Based Scaffolds
- Scaffold Free
- Hanging Drop Microplates
- Spheroid Microplates with ULA coating
- Magnetic Levitation
- Bioreactors
- Microfluidics
- Bioprinting
- Scaffold Based
- Spain 3D Cell Culture Market, By Application, 2018 - 2030 (USD Million)
- Cancer Research
- Stem Cell Research & Tissue Engineering
- Drug Development & Toxicity Testing
- Others
- Spain 3D Cell Culture Market, By End Use, 2018 - 2030 (USD Million)
- Biotechnology & Pharmaceutical Companies
- Academic & Research Institutes
- Hospitals
- Others
- Spain 3D Cell Culture Market, By Technology, 2018 - 2030 (USD Million)
- Denmark
- Denmark 3D Cell Culture Market, By Technology, 2018 - 2030 (USD Million)
- Scaffold Based
- Hydrogels
- Polymeric Scaffolds
- Micropatterned Surface Microplates
- Nanofiber Based Scaffolds
- Scaffold Free
- Hanging Drop Microplates
- Spheroid Microplates with ULA coating
- Magnetic Levitation
- Bioreactors
- Microfluidics
- Bioprinting
- Scaffold Based
- Denmark 3D Cell Culture Market, By Application, 2018 - 2030 (USD Million)
- Cancer Research
- Stem Cell Research & Tissue Engineering
- Drug Development & Toxicity Testing
- Others
- Denmark 3D Cell Culture Market, By End Use, 2018 - 2030 (USD Million)
- Biotechnology & Pharmaceutical Companies
- Academic & Research Institutes
- Hospitals
- Others
- Denmark 3D Cell Culture Market, By Technology, 2018 - 2030 (USD Million)
- Sweden
- Sweden 3D Cell Culture Market, By Technology, 2018 - 2030 (USD Million)
- Scaffold Based
- Hydrogels
- Polymeric Scaffolds
- Micropatterned Surface Microplates
- Nanofiber Based Scaffolds
- Scaffold Free
- Hanging Drop Microplates
- Spheroid Microplates with ULA coating
- Magnetic Levitation
- Bioreactors
- Microfluidics
- Bioprinting
- Scaffold Based
- Sweden 3D Cell Culture Market, By Application, 2018 - 2030 (USD Million)
- Cancer Research
- Stem Cell Research & Tissue Engineering
- Drug Development & Toxicity Testing
- Others
- Sweden 3D Cell Culture Market, By End Use, 2018 - 2030 (USD Million)
- Biotechnology & Pharmaceutical Companies
- Academic & Research Institutes
- Hospitals
- Others
- Sweden 3D Cell Culture Market, By Technology, 2018 - 2030 (USD Million)
- Norway
- Norway 3D Cell Culture Market, By Technology, 2018 - 2030 (USD Million)
- Scaffold Based
- Hydrogels
- Polymeric Scaffolds
- Micropatterned Surface Microplates
- Nanofiber Based Scaffolds
- Scaffold Free
- Hanging Drop Microplates
- Spheroid Microplates with ULA coating
- Magnetic Levitation
- Bioreactors
- Microfluidics
- Bioprinting
- Scaffold Based
- Norway 3D Cell Culture Market, By Application, 2018 - 2030 (USD Million)
- Cancer Research
- Stem Cell Research & Tissue Engineering
- Drug Development & Toxicity Testing
- Others
- Norway 3D Cell Culture Market, By End Use, 2018 - 2030 (USD Million)
- Biotechnology & Pharmaceutical Companies
- Academic & Research Institutes
- Hospitals
- Others
- Norway 3D Cell Culture Market, By Technology, 2018 - 2030 (USD Million)
- Europe 3D Cell Culture Market, By Technology, 2018 - 2030 (USD Million)
- Asia Pacific
- Asia Pacific 3D Cell Culture Market, By Technology, 2018 - 2030 (USD Million)
- Scaffold Based
- Hydrogels
- Polymeric Scaffolds
- Micropatterned Surface Microplates
- Nanofiber Based Scaffolds
- Scaffold Free
- Hanging Drop Microplates
- Spheroid Microplates with ULA coating
- Magnetic Levitation
- Bioreactors
- Microfluidics
- Bioprinting
- Scaffold Based
- Asia Pacific 3D Cell Culture Market, By Application, 2018 - 2030 (USD Million)
- Cancer Research
- Stem Cell Research & Tissue Engineering
- Drug Development & Toxicity Testing
- Others
- Asia Pacific 3D Cell Culture Market, By End Use, 2018 - 2030 (USD Million)
- Biotechnology & Pharmaceutical Companies
- Academic & Research Institutes
- Hospitals
- Others
- China
- China 3D Cell Culture Market, By Technology, 2018 - 2030 (USD Million)
- Scaffold Based
- Hydrogels
- Polymeric Scaffolds
- Micropatterned Surface Microplates
- Nanofiber Based Scaffolds
- Scaffold Free
- Hanging Drop Microplates
- Spheroid Microplates with ULA coating
- Magnetic Levitation
- Bioreactors
- Microfluidics
- Bioprinting
- Scaffold Based
- China 3D Cell Culture Market, By Application, 2018 - 2030 (USD Million)
- Cancer Research
- Stem Cell Research & Tissue Engineering
- Drug Development & Toxicity Testing
- Others
- China 3D Cell Culture Market, By End Use, 2018 - 2030 (USD Million)
- Biotechnology & Pharmaceutical Companies
- Academic & Research Institutes
- Hospitals
- Others
- China 3D Cell Culture Market, By Technology, 2018 - 2030 (USD Million)
- Japan
- Japan 3D Cell Culture Market, By Technology, 2018 - 2030 (USD Million)
- Scaffold Based
- Hydrogels
- Polymeric Scaffolds
- Micropatterned Surface Microplates
- Nanofiber Based Scaffolds
- Scaffold Free
- Hanging Drop Microplates
- Spheroid Microplates with ULA coating
- Magnetic Levitation
- Bioreactors
- Microfluidics
- Bioprinting
- Scaffold Based
- Japan 3D Cell Culture Market, By Application, 2018 - 2030 (USD Million)
- Cancer Research
- Stem Cell Research & Tissue Engineering
- Drug Development & Toxicity Testing
- Others
- Japan 3D Cell Culture Market, By End Use, 2018 - 2030 (USD Million)
- Biotechnology & Pharmaceutical Companies
- Academic & Research Institutes
- Hospitals
- Others
- Japan 3D Cell Culture Market, By Technology, 2018 - 2030 (USD Million)
- India
- India 3D Cell Culture Market, By Technology, 2018 - 2030 (USD Million)
- Scaffold Based
- Hydrogels
- Polymeric Scaffolds
- Micropatterned Surface Microplates
- Nanofiber Based Scaffolds
- Scaffold Free
- Hanging Drop Microplates
- Spheroid Microplates with ULA coating
- Magnetic Levitation
- Bioreactors
- Microfluidics
- Bioprinting
- Scaffold Based
- India 3D Cell Culture Market, By Application, 2018 - 2030 (USD Million)
- Cancer Research
- Stem Cell Research & Tissue Engineering
- Drug Development & Toxicity Testing
- Others
- India 3D Cell Culture Market, By End Use, 2018 - 2030 (USD Million)
- Biotechnology & Pharmaceutical Companies
- Academic & Research Institutes
- Hospitals
- Others
- India 3D Cell Culture Market, By Technology, 2018 - 2030 (USD Million)
- Australia
- Australia 3D Cell Culture Market, By Technology, 2018 - 2030 (USD Million)
- Scaffold Based
- Hydrogels
- Polymeric Scaffolds
- Micropatterned Surface Microplates
- Nanofiber Based Scaffolds
- Scaffold Free
- Hanging Drop Microplates
- Spheroid Microplates with ULA coating
- Magnetic Levitation
- Bioreactors
- Microfluidics
- Bioprinting
- Scaffold Based
- Australia 3D Cell Culture Market, By Application, 2018 - 2030 (USD Million)
- Cancer Research
- Stem Cell Research & Tissue Engineering
- Drug Development & Toxicity Testing
- Others
- Australia 3D Cell Culture Market, By End Use, 2018 - 2030 (USD Million)
- Biotechnology & Pharmaceutical Companies
- Academic & Research Institutes
- Hospitals
- Others
- Australia 3D Cell Culture Market, By Technology, 2018 - 2030 (USD Million)
- Thailand
- Thailand 3D Cell Culture Market, By Technology, 2018 - 2030 (USD Million)
- Scaffold Based
- Hydrogels
- Polymeric Scaffolds
- Micropatterned Surface Microplates
- Nanofiber Based Scaffolds
- Scaffold Free
- Hanging Drop Microplates
- Spheroid Microplates with ULA coating
- Magnetic Levitation
- Bioreactors
- Microfluidics
- Bioprinting
- Scaffold Based
- Thailand 3D Cell Culture Market, By Application, 2018 - 2030 (USD Million)
- Cancer Research
- Stem Cell Research & Tissue Engineering
- Drug Development & Toxicity Testing
- Others
- Thailand 3D Cell Culture Market, By End Use, 2018 - 2030 (USD Million)
- Biotechnology & Pharmaceutical Companies
- Academic & Research Institutes
- Hospitals
- Others
- Thailand 3D Cell Culture Market, By Technology, 2018 - 2030 (USD Million)
- South Korea
- South Korea 3D Cell Culture Market, By Technology, 2018 - 2030 (USD Million)
- Scaffold Based
- Hydrogels
- Polymeric Scaffolds
- Micropatterned Surface Microplates
- Nanofiber Based Scaffolds
- Scaffold Free
- Hanging Drop Microplates
- Spheroid Microplates with ULA coating
- Magnetic Levitation
- Bioreactors
- Microfluidics
- Bioprinting
- Scaffold Based
- South Korea 3D Cell Culture Market, By Application, 2018 - 2030 (USD Million)
- Cancer Research
- Stem Cell Research & Tissue Engineering
- Drug Development & Toxicity Testing
- Others
- South Korea 3D Cell Culture Market, By End Use, 2018 - 2030 (USD Million)
- Biotechnology & Pharmaceutical Companies
- Academic & Research Institutes
- Hospitals
- Others
- South Korea 3D Cell Culture Market, By Technology, 2018 - 2030 (USD Million)
- Asia Pacific 3D Cell Culture Market, By Technology, 2018 - 2030 (USD Million)
- Latin America
- Latin America 3D Cell Culture Market, By Technology, 2018 - 2030 (USD Million)
- Scaffold Based
- Hydrogels
- Polymeric Scaffolds
- Micropatterned Surface Microplates
- Nanofiber Based Scaffolds
- Scaffold Free
- Hanging Drop Microplates
- Spheroid Microplates with ULA coating
- Magnetic Levitation
- Bioreactors
- Microfluidics
- Bioprinting
- Scaffold Based
- Latin America 3D Cell Culture Market, By Application, 2018 - 2030 (USD Million)
- Cancer Research
- Stem Cell Research & Tissue Engineering
- Drug Development & Toxicity Testing
- Others
- Latin America 3D Cell Culture Market, By End Use, 2018 - 2030 (USD Million)
- Biotechnology & Pharmaceutical Companies
- Academic & Research Institutes
- Hospitals
- Others
- Brazil
- Brazil 3D Cell Culture Market, By Technology, 2018 - 2030 (USD Million)
- Scaffold Based
- Hydrogels
- Polymeric Scaffolds
- Micropatterned Surface Microplates
- Nanofiber Based Scaffolds
- Scaffold Free
- Hanging Drop Microplates
- Spheroid Microplates with ULA coating
- Magnetic Levitation
- Bioreactors
- Microfluidics
- Bioprinting
- Scaffold Based
- Brazil 3D Cell Culture Market, By Application, 2018 - 2030 (USD Million)
- Cancer Research
- Stem Cell Research & Tissue Engineering
- Drug Development & Toxicity Testing
- Others
- Brazil 3D Cell Culture Market, By End Use, 2018 - 2030 (USD Million)
- Biotechnology & Pharmaceutical Companies
- Academic & Research Institutes
- Hospitals
- Others
- Brazil 3D Cell Culture Market, By Technology, 2018 - 2030 (USD Million)
- Mexico
- Mexico 3D Cell Culture Market, By Technology, 2018 - 2030 (USD Million)
- Scaffold Based
- Hydrogels
- Polymeric Scaffolds
- Micropatterned Surface Microplates
- Nanofiber Based Scaffolds
- Scaffold Free
- Hanging Drop Microplates
- Spheroid Microplates with ULA coating
- Magnetic Levitation
- Bioreactors
- Microfluidics
- Bioprinting
- Scaffold Based
- Mexico 3D Cell Culture Market, By Application, 2018 - 2030 (USD Million)
- Cancer Research
- Stem Cell Research & Tissue Engineering
- Drug Development & Toxicity Testing
- Others
- Mexico 3D Cell Culture Market, By End Use, 2018 - 2030 (USD Million)
- Biotechnology & Pharmaceutical Companies
- Academic & Research Institutes
- Hospitals
- Others
- Mexico 3D Cell Culture Market, By Technology, 2018 - 2030 (USD Million)
- Argentina
- Argentina 3D Cell Culture Market, By Technology, 2018 - 2030 (USD Million)
- Scaffold Based
- Hydrogels
- Polymeric Scaffolds
- Micropatterned Surface Microplates
- Nanofiber Based Scaffolds
- Scaffold Free
- Hanging Drop Microplates
- Spheroid Microplates with ULA coating
- Magnetic Levitation
- Bioreactors
- Microfluidics
- Bioprinting
- Scaffold Based
- Argentina 3D Cell Culture Market, By Application, 2018 - 2030 (USD Million)
- Cancer Research
- Stem Cell Research & Tissue Engineering
- Drug Development & Toxicity Testing
- Others
- Argentina 3D Cell Culture Market, By End Use, 2018 - 2030 (USD Million)
- Biotechnology & Pharmaceutical Companies
- Academic & Research Institutes
- Hospitals
- Others
- Argentina 3D Cell Culture Market, By Technology, 2018 - 2030 (USD Million)
- Latin America 3D Cell Culture Market, By Technology, 2018 - 2030 (USD Million)
- Middle East & Africa
- Middle East & Africa 3D Cell Culture Market, By Technology, 2018 - 2030 (USD Million)
- Scaffold Based
- Hydrogels
- Polymeric Scaffolds
- Micropatterned Surface Microplates
- Nanofiber Based Scaffolds
- Scaffold Free
- Hanging Drop Microplates
- Spheroid Microplates with ULA coating
- Magnetic Levitation
- Bioreactors
- Microfluidics
- Bioprinting
- Scaffold Based
- Middle East & Africa 3D Cell Culture Market, By Application, 2018 - 2030 (USD Million)
- Cancer Research
- Stem Cell Research & Tissue Engineering
- Drug Development & Toxicity Testing
- Others
- Middle East & Africa 3D Cell Culture Market, By End Use, 2018 - 2030 (USD Million)
- Biotechnology & Pharmaceutical Companies
- Academic & Research Institutes
- Hospitals
- Others
- South Africa
- South Africa 3D Cell Culture Market, By Technology, 2018 - 2030 (USD Million)
- Scaffold Based
- Hydrogels
- Polymeric Scaffolds
- Micropatterned Surface Microplates
- Nanofiber Based Scaffolds
- Scaffold Free
- Hanging Drop Microplates
- Spheroid Microplates with ULA coating
- Magnetic Levitation
- Bioreactors
- Microfluidics
- Bioprinting
- Scaffold Based
- South Africa 3D Cell Culture Market, By Application, 2018 - 2030 (USD Million)
- Cancer Research
- Stem Cell Research & Tissue Engineering
- Drug Development & Toxicity Testing
- Others
- South Africa 3D Cell Culture Market, By End Use, 2018 - 2030 (USD Million)
- Biotechnology & Pharmaceutical Companies
- Academic & Research Institutes
- Hospitals
- Others
- South Africa 3D Cell Culture Market, By Technology, 2018 - 2030 (USD Million)
- Saudi Arabia
- Saudi Arabia 3D Cell Culture Market, By Technology, 2018 - 2030 (USD Million)
- Scaffold Based
- Hydrogels
- Polymeric Scaffolds
- Micropatterned Surface Microplates
- Nanofiber Based Scaffolds
- Scaffold Free
- Hanging Drop Microplates
- Spheroid Microplates with ULA coating
- Magnetic Levitation
- Bioreactors
- Microfluidics
- Bioprinting
- Scaffold Based
- Saudi Arabia 3D Cell Culture Market, By Application, 2018 - 2030 (USD Million)
- Cancer Research
- Stem Cell Research & Tissue Engineering
- Drug Development & Toxicity Testing
- Others
- Saudi Arabia 3D Cell Culture Market, By End Use, 2018 - 2030 (USD Million)
- Biotechnology & Pharmaceutical Companies
- Academic & Research Institutes
- Hospitals
- Others
- Saudi Arabia 3D Cell Culture Market, By Technology, 2018 - 2030 (USD Million)
- UAE
- UAE 3D Cell Culture Market, By Technology, 2018 - 2030 (USD Million)
- Scaffold Based
- Hydrogels
- Polymeric Scaffolds
- Micropatterned Surface Microplates
- Nanofiber Based Scaffolds
- Scaffold Free
- Hanging Drop Microplates
- Spheroid Microplates with ULA coating
- Magnetic Levitation
- Bioreactors
- Microfluidics
- Bioprinting
- Scaffold Based
- UAE 3D Cell Culture Market, By Application, 2018 - 2030 (USD Million)
- Cancer Research
- Stem Cell Research & Tissue Engineering
- Drug Development & Toxicity Testing
- Others
- UAE 3D Cell Culture Market, By End Use, 2018 - 2030 (USD Million)
- Biotechnology & Pharmaceutical Companies
- Academic & Research Institutes
- Hospitals
- Others
- UAE 3D Cell Culture Market, By Technology, 2018 - 2030 (USD Million)
- Kuwait
- Kuwait 3D Cell Culture Market, By Technology, 2018 - 2030 (USD Million)
- Scaffold Based
- Hydrogels
- Polymeric Scaffolds
- Micropatterned Surface Microplates
- Nanofiber Based Scaffolds
- Scaffold Free
- Hanging Drop Microplates
- Spheroid Microplates with ULA coating
- Magnetic Levitation
- Bioreactors
- Microfluidics
- Bioprinting
- Scaffold Based
- Kuwait 3D Cell Culture Market, By Application, 2018 - 2030 (USD Million)
- Cancer Research
- Stem Cell Research & Tissue Engineering
- Drug Development & Toxicity Testing
- Others
- Kuwait 3D Cell Culture Market, By End Use, 2018 - 2030 (USD Million)
- Biotechnology & Pharmaceutical Companies
- Academic & Research Institutes
- Hospitals
- Others
- Kuwait 3D Cell Culture Market, By Technology, 2018 - 2030 (USD Million)
- Middle East & Africa 3D Cell Culture Market, By Technology, 2018 - 2030 (USD Million)
- North America
3D Cell Culture Market Dynamics
Driver-Rising demand for organ transplantation & tissue engineering
3D cell culture platforms provide advanced tools that help explore key aspects of any disease and enable the elucidation of microenvironmental factors supporting in vivo tumor growth. The 3D concept of artificial cell cultivation offers huge benefits in the investigation of phenotypic heterogeneity of cancer cells and heterotypic intercellular crosstalk. Ability of 3D cellular models to overcome the flaws associated with 2D monolayer cell culture is anticipated to fuel demand for 3D cell culture techniques in the near future. The shift from 2D to 3D technique is rapidly progressing, which is consequently boosting the growth of this market. Application of 3D cell culture techniques in performing real-time mammalian study yields physiologically relevant information that supports the development of effective drugs against diseases, which is anticipated to enhance the market growth in the coming years. Moreover, biomimetic tissue constructs used to generate 3D organotypic structures drove a large number of research entities to adopt 3D cell culture techniques. In addition, the usage of 3D tissue-engineered models for cancer research emerged as an alternative approach to traditional methods and exhibited great potential in providing a relatively simple and inexpensive in vitro tumor-host environment compared to traditional methods. Entry of new market players in this segment due to the high market potential of 3D cell culture is expected to further propel the market.
Driver-Technological advancements in scaffold-free technology
Switching to 3D cell culture techniques from conventional cell culture methods is expected to revolutionize the cell culture market through 2025. Major factors responsible for this growth are its wide applicability in biological research and the launch of new technologies in the 3D cell culture platform. For instance, the Nunclon Sphera 3D culture platform developed by Thermo Fisher Scientific facilitates the easy transition of cell cultures from 2D to 3D without the aid of additional culture conditions, microscope, or media. Similarly, standard 2D analysis methods can easily be applied on RAFT 3D cultures manufactured by Lonza. Therefore, as these novel technologies do not require much changes to the already existing 2D cell culture methods, they are adopted by many laboratories across the globe. In addition, Lonza has also developed 3D cell culture models to enhance research in areas of hepatic signaling pathways and drug-induced liver injury to enhance in vitro hepatotoxicity testing.
Restraint-High cost associated with implementation
Significant growth in terms of product portfolio expansion within the research organizations is supporting the development of advanced techniques in the cell culture market for drug development and toxicity screening. 3D models have played a crucial role in enabling a greater understanding of tumors and cell behavior in diseased conditions, consequently raising the market demand. However, expenses associated with the implementation of 3D cell culture are still not affordable for several regions, which restrains market growth. 3D cell culture materials and scaffolds are more expensive when compared to 2D tissue culture equipment. This is a concern for the pharmaceutical industry where the drug discovery process needs a multitude of experiments and thereby increases the overall cost. Moreover, synthetic hydrogels and ECM proteins further add to the existing cost and also need expert handling skills. Despite this challenge, the rise in global investments, mainly due to governments & funding bodies, and the presence of CROs are supporting the adoption of this technique for cell-based assays.
What Does This Report Include?
This section will provide insights into the contents included in this 3d cell culture market report and help gain clarity on the structure of the report to assist readers in navigating smoothly.
3d cell culture market qualitative analysis
-
Industry overview
-
Industry trends
-
Market drivers and restraints
-
Market size
-
Growth prospects
-
Porter’s analysis
-
PESTEL analysis
-
Key market opportunities prioritized
-
Competitive landscape
-
Company overview
-
Financial performance
-
Product benchmarking
-
Latest strategic developments
-
3d cell culture market quantitative analysis
-
Market size, estimates, and forecast from 2018 to 2030
-
Market estimates and forecast for product segments up to 2030
-
Regional market size and forecast for product segments up to 2030
-
Market estimates and forecast for application segments up to 2030
-
Regional market size and forecast for application segments up to 2030
-
Company financial performance
Research Methodology
A three-pronged approach was followed for deducing the 3d cell culture market estimates and forecasts. The process has three steps: information procurement, analysis, and validation. The whole process is cyclical, and steps repeat until the estimates are validated. The three steps are explained in detail below:
Information procurement: Information procurement is one of the most extensive and important stages in our research process, and quality data is critical for accurate analysis. We followed a multi-channel data collection process for 3d cell culture market to gather the most reliable and current information possible.
- We buy access to paid databases such as Hoover’s and Factiva for company financials, industry information, white papers, industry journals, SME journals, and more.
- We tap into Grand View’s proprietary database of data points and insights from active and archived monitoring and reporting.
- We conduct primary research with industry experts through questionnaires and one-on-one phone interviews.
- We pull from reliable secondary sources such as white papers and government statistics, published by organizations like WHO, NGOs, World Bank, etc., Key Opinion Leaders (KoL) publications, company filings, investor documents, and more.
- We purchase and review investor analyst reports, broker reports, academic commentary, government quotes, and wealth management publications for insightful third-party perspectives.
Analysis: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilized different methods of 3d cell culture market data depending on the type of information we’re trying to uncover in our research.
-
Market Research Efforts: Bottom-up Approach for estimating and forecasting demand size and opportunity, top-down Approach for new product forecasting and penetration, and combined approach of both Bottom-up and Top-down for full coverage analysis.
-
Value-Chain-Based Sizing & Forecasting: Supply-side estimates for understanding potential revenue through competitive benchmarking, forecasting, and penetration modeling.
-
Demand-side estimates for identifying parent and ancillary markets, segment modeling, and heuristic forecasting.
-
Qualitative Functional Deployment (QFD) Modelling for market share assessment.
Market formulation and validation: We mine the data collected to establish baselines for forecasting, identify trends and opportunities, gain insight into consumer demographics and drivers, and so much more. We utilize different methods of data analysis depending on the type of information we’re trying to uncover in our research.
-
Market Formulation: This step involves the finalization of market numbers. This step on an internal level is designed to manage outputs from the Data Analysis step.
-
Data Normalization: The final market estimates and forecasts are then aligned and sent to industry experts, in-panel quality control managers for validation.
-
This step also entails the finalization of the report scope and data representation pattern.
-
Validation: The process entails multiple levels of validation. All these steps run in parallel, and the study is forwarded for publishing only if all three levels render validated results.
3D Cell Culture Market Categorization:
The 3d cell culture market was categorized into four segments, namely technology (Scaffold Based, Scaffold Free, Bioreactors, Microfluidics, Bioprinting), application (Cancer Research, Stem Cell Research & Tissue Engineering, Drug Development & Toxicity Testing), end-use (Biotechnology And Pharmaceutical Companies, Academic & Research Institutes, Hospitals), and regions (North America, Europe, Asia Pacific, Latin America, Middle East & Africa).
Segment Market Methodology:
The 3d cell culture market was segmented into technology, application, end-use, and regions. The demand at a segment level was deduced using a funnel method. Concepts like the TAM, SAM, SOM, etc., were put into practice to understand the demand. We at GVR deploy three methods to deduce market estimates and determine forecasts. These methods are explained below:
Market research approaches: Bottom-up
-
Demand estimation of each product across countries/regions summed up to from the total market.
-
Variable analysis for demand forecast.
-
Demand estimation via analyzing paid database, and company financials either via annual reports or paid database.
-
Primary interviews for data revalidation and insight collection.
Market research approaches: Top-down
-
Used extensively for new product forecasting or analyzing penetration levels.
-
Tool used invoice product flow and penetration models Use of regression multi-variant analysis for forecasting Involves extensive use of paid and public databases.
-
Primary interviews and vendor-based primary research for variable impact analysis.
Market research approaches: Combined
- This is the most common method. We apply concepts from both the top-down and bottom-up approaches to arrive at a viable conclusion.
Regional Market Methodology:
The 3d cell culture market was analyzed at a regional level. The globe was divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, keeping in focus variables like consumption patterns, export-import regulations, consumer expectations, etc. These regions were further divided into twenty-three countries, namely, the U.S.; Canada; Germany; the UK; France; Italy; Spain; Denmark; Sweden; Norway; China; Japan; India; South Korea; Australia; Thailand; Brazil; Mexico, Argentina; South Africa; Saudi Arabia, UAE; and Kuwait.
All three above-mentioned market research methodologies were applied to arrive at regional-level conclusions. The regions were then summed up to form the global market.
3D cell culture market companies & financials:
The 3d cell culture market was analyzed via companies operating in the sector. Analyzing these companies and cross-referencing them to the demand equation helped us validate our assumptions and conclusions. Key market players analyzed include:
-
Merck KGaA - Merck KGaA is a German multinational company that provides healthcare solutions and materials. It operates through three sectors: healthcare, life sciences, and performance materials. It operates in North America, Europe, Asia, Latin America, Oceania, and Africa. In November 2015, Merck announced the acquisition of Sigma-Aldrich Co. LLC, and it began operating as a subsidiary of Merck KGaA.
-
Sigma-Aldrich Co. LLC - The company operates through three market-focused business units: research, SAFC commercials, and applied business. Through these units, it provides more than 200,000 products and tools in different categories, which include analytical, chromatography, spectroscopy, acid-base titration, inorganic catalysts, chemical synthesis, organometallics, and salts & solvents. Life sciences products include antibiotics, biochemical & reagents, enzymes, inhibitors, and substrates. The company is present in over 37 countries with around 9,600 employees globally. The services they offer include basic research, products & process development, manufacturing & production, and regulatory compliance with custom capabilities, such as small- and large-molecule manufacturing, drug & process development, and genomic & proteomic solutions.
-
Thermo Fisher Scientific, Inc. - Thermo Fisher Scientific, Inc. is a publicly held biotechnology company established after the collaboration of Thermo Electron and Fisher Scientific. In 2013, in a competitive bidding with Hoffman La Roche, it acquired Life Technologies Corporation. Thermo Fisher provides product in life science, industrial & applied science, and clinical diagnostics. The company has operations in over 50 countries. Thermo Fisher offers products through the following brands: Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services.
-
PromoCell GmbH - The company has around 5,000 Promocell and PromoKine products designed to aide research activities. The company offers broad range of products such as stem cell, human primary cell, blood cell, and optimized cell culture media. The Promokine kits and reagents for cell biology include cell transfection, cell analysis, and fluorescent labeling. In addition to these, it also has antibodies, cytokines, ELISAs, and growth factors in its basket. Subsidiary branches of company are located in Austria, China, France, Germany, Japan, and other countries. In 2004, company established PromoCell Academy, which offers courses in life science field.
-
Greiner Bio One International GmbH - Greiner Bio-One International GmbH operates as an operating division of Greiner AG. The company is active in the medical technology market through its four business divisions, namely preanalytics, BioScience, diagnostics, and Original Equipment Manufacturer (OEM). The BioScience division works as a technology partner to research organizations, universities, and pharmaceutical & diagnostics companies. The division supplies specialized products to analyze cell cultures and microplates. In May 2018, Greiner Bio-One North America, Inc., a subsidiary of Greiner Bio-One International GmbH, acquired 3D Cell Culture Technology from Nano3D Biosciences, Inc.
-
Nano3D Biosciences, Inc. - Nano3D Biosciences, Inc. (n3D) is established by four PhDs: Glauco R. Souza, David J. Lee, Thomas C. Killian, and Robert M. Raphael. It provides solutions in biomedical research, drug discovery, toxicology, precision medicine, and regenerative medicine. Its service portfolio includes assay development, vasoactivity screening, oncology screening, toxicity screening, and wound healing screening. It has a partnership with Greiner Bio-One, which provides its platform for 3D cell culture.
-
3D Biomatrix - This company is actively involved in delivering 3D cell culture solutions for life science research and drug discovery. It offers platforms for cancer research, stem cell research, and toxicity screening. Its distributors include Sigma-Aldrich; Cell Guidance Systems Ltd; CEDARLANE Laboratories USA, Inc.; Dot Scientific, Inc.; Fisher Scientific, Inc.; Volt Tecnologia; and others.
-
Lonza - Lonza is a worldwide supplier of biopharmaceuticals. This company offers product ranges in bioresearch, consumer care, Pharma & biotech, water treatment, agro ingredients, industrial solutions, and wood protection. The company’s market is segmented into pharma & biotech and specialty ingredients. In March 2009, the company joined the United Nations Global Compact as a strategic initiative to enhance its business. Lonza has its worldwide operations in North America, Europe, Asia, France, United Kingdom, and others.
-
Avantor Performance Materials, LLC - Avantor is involved in the production and sales of high-quality products, solutions, and services for professionals in the field of life sciences and other advanced technology businesses. The company operates from more than 30 countries globally, offering a diverse product portfolio of more than 4 million products. The company’s offerings are used in biopharmaceutical, pharmaceutical, medical device, diagnostics, healthcare, educational, industrial, government, aerospace & defense, and semiconductor industries. In November 2017, the company acquired VWR Corporation and operates in the 3D cell culture market through it.
-
VWR International, LLC - VWR International, LLC is headquartered in Pennsylvania. It is a provider and distributor of solutions, products, and services to laboratories worldwide. VWR LLC has around 160 years of experience. It is a leading distributor of many major pharmaceutical, biotechnology, and instrument manufacturing companies. VWR has 160 distribution facilities globally. It has the largest distribution center of around 500,000 square feet in Visalia, CA. The client base of the company includes academic institutions, smaller businesses, and R&D centers of major life science companies.
Value chain-based sizing & forecasting
Supply Side Estimates
-
Company revenue estimation via referring to annual reports, investor presentations, and Hoover’s.
-
Segment revenue determination via variable analysis and penetration modeling.
-
Competitive benchmarking to identify market leaders and their collective revenue shares.
-
Forecasting via analyzing commercialization rates, pipelines, market initiatives, distribution networks, etc.
Demand side estimates
-
Identifying parent markets and ancillary markets
-
Segment penetration analysis to obtain pertinent
-
revenue/volume
-
Heuristic forecasting with the help of subject matter experts
-
Forecasting via variable analysis
3D Cell Culture Market Report Objectives:
-
Understanding market dynamics (in terms of drivers, restraints, & opportunities) in the countries.
-
Understanding trends & variables in the individual countries & their impact on growth and using analytical tools to provide high-level insights into the market dynamics and the associated growth pattern.
-
Understanding market estimates and forecasts (with the base year as 2022, historic information from 2018 to 2021, and forecast from 2023 to 2030). Regional estimates & forecasts for each category are available and are summed up to form the global market estimates.
3D Cell Culture Market Report Assumptions:
-
The report provides market value for the base year 2022 and a yearly forecast till 2030 in terms of revenue/volume or both. The market for each of the segment outlooks has been provided on region & country basis for the above-mentioned forecast period.
-
The key industry dynamics, major technological trends, and application markets are evaluated to understand their impact on the demand for the forecast period. The growth rates were estimated using correlation, regression, and time-series analysis.
-
We have used the bottom-up approach for market sizing, analyzing key regional markets, dynamics, & trends for various products and end-users. The total market has been estimated by integrating the country markets.
-
All market estimates and forecasts have been validated through primary interviews with the key industry participants.
-
Inflation has not been accounted for to estimate and forecast the market.
-
Numbers may not add up due to rounding off.
-
Europe consists of EU-8, Central & Eastern Europe, along with the Commonwealth of Independent States (CIS).
-
Asia Pacific includes South Asia, East Asia, Southeast Asia, and Oceania (Australia & New Zealand).
-
Latin America includes Central American countries and the South American continent
-
Middle East includes Western Asia (as assigned by the UN Statistics Division) and the African continent.
Primary Research
GVR strives to procure the latest and unique information for reports directly from industry experts, which gives it a competitive edge. Quality is of utmost importance to us, therefore every year we focus on increasing our experts’ panel. Primary interviews are one of the critical steps in identifying recent market trends and scenarios. This process enables us to justify and validate our market estimates and forecasts to our clients. With more than 8,000 reports in our database, we have connected with some key opinion leaders across various domains, including healthcare, technology, consumer goods, and the chemical sector. Our process starts with identifying the right platform for a particular type of report, i.e., emails, LinkedIn, seminars, or telephonic conversation, as every report is unique and requires a differentiated approach.
We send out questionnaires to different experts from various regions/ countries, which is dependent on the following factors:
-
Report/Market scope: If the market study is global, we send questionnaires to industry experts across various regions, including North America, Europe, Asia Pacific, Latin America, and MEA.
-
Market Penetration: If the market is driven by technological advancements, population density, disease prevalence, or other factors, we identify experts and send out questionnaires based on region or country dominance.
The time to start receiving responses from industry experts varies based on how niche or well-penetrated the market is. Our reports include a detailed chapter on the KoL opinion section, which helps our clients understand the perspective of experts already in the market space.
![pdf icn]()
GET A FREE SAMPLE
![arrow icn]()
This FREE sample includes data points, ranging from trend analyses to estimates and forecasts. See for yourself.
![gvr icn]()
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
![Certified Icon]()
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
We are committed towards customer satisfaction, and quality service.
"The quality of research they have done for us has been excellent."
